Pamelor and Triamcinolone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pamelor (nortriptyline hydrochloride) and Triamcinolone (triamcinolone). Common drug interactions include surgery among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Pamelor and Triamcinolone. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Pamelor?

Pamelor has active ingredients of nortriptyline hydrochloride. It is often used in migraine. eHealthMe is studying from 4,069 Pamelor users. Check the latest studies of Pamelor.

What is Triamcinolone?

Triamcinolone has active ingredients of triamcinolone. eHealthMe is studying from 25,577 Triamcinolone users. Check the latest studies of Triamcinolone.



On Apr, 24, 2026

23 people who take Pamelor and Triamcinolone together, and have interactions are studied.

Pamelor and Triamcinolone drug interactions.

What are the common drug interactions of Pamelor and Triamcinolone, by gender? *:

female:

  1. Surgery
  2. Asthma
  3. Blood pressure increased
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Chronic kidney disease
  6. Hypoglycaemia (deficiency of glucose in the bloodstream)
  7. Infection
  8. Neuropathy peripheral (surface nerve damage)
  9. Psoriasis (immune-mediated disease that affects the skin)
  10. Pulmonary mass

male:

  1. Chronic kidney disease
  2. Drug ineffective
  3. Death
  4. Decreased appetite
  5. Difficulty in walking
  6. Drug hypersensitivity
  7. Fatigue (feeling of tiredness)
  8. Food allergy
  9. Hypersomnia (excessive daytime sleepiness (eds))
  10. Hypoaesthesia (reduced sense of touch or sensation)

What are the common drug interactions of Pamelor and Triamcinolone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Infection
  5. Psoriasis (immune-mediated disease that affects the skin)
  6. Renal tubular necrosis (death of kidney tubules)
  7. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  8. Arthralgia (joint pain)
  9. Alopecia (absence of hair from areas of the body)
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

60+:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Balance disorder
  3. Peripheral motor neuropathy (muscles in the body become progressively weaker over months to years)
  4. Pneumonia
  5. Portal hypertensive gastropathy (changes in the mucosa of the stomach in patients with portal hypertension;)
  6. Rash
  7. Decreased appetite
  8. Difficulty in walking
  9. Fall
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 43.48%
  2. Pain: 6 people, 26.09%
  3. Diabetes: 5 people, 21.74%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 17.39%
  5. Depression: 4 people, 17.39%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 13.04%
  7. Psoriasis (immune-mediated disease that affects the skin): 3 people, 13.04%
  8. Drowsiness: 3 people, 13.04%
  9. High Blood Pressure: 3 people, 13.04%
  10. Fungal Infection: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Pamelor and Triamcinolone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pamelor and Triamcinolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pamelor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Triamcinolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pamelor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Triamcinolone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nortriptyline hydrochloride and triamcinolone (the active ingredients of Pamelor and Triamcinolone, respectively), and Pamelor and Triamcinolone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: